G
Gail L. Woods
Researcher at University of Arkansas for Medical Sciences
Publications - 38
Citations - 2698
Gail L. Woods is an academic researcher from University of Arkansas for Medical Sciences. The author has contributed to research in topics: Aspergillosis & Galactomannan. The author has an hindex of 21, co-authored 38 publications receiving 2392 citations. Previous affiliations of Gail L. Woods include University of Utah & ARUP Laboratories.
Papers
More filters
Journal ArticleDOI
Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children
David M. Lewinsohn,Michael K. Leonard,Philip A. LoBue,David L. Cohn,Charles L. Daley,Ed Desmond,Joseph Keane,Deborah A. Lewinsohn,Ann M. Loeffler,Gerald H. Mazurek,Richard J. O'Brien,Madhukar Pai,Luca Richeldi,Max Salfinger,Thomas M. Shinnick,Timothy R. Sterling,David M. Warshauer,Gail L. Woods +17 more
TL;DR: Twenty-three evidence-based recommendations about diagnostic testing for latent tuberculosis infection, pulmonary tuberculosis, and extrapulmonary tuberculosis are provided and six of the recommendations are strong, whereas the remaining 17 are conditional.
Journal ArticleDOI
Evaluation of a (1→3)-β-d-Glucan Assay for Diagnosis of Invasive Fungal Infections
Jerry W. Pickering,Howard W. Sant,Catherine A. P. Bowles,Catherine A. P. Bowles,William L. Roberts,William L. Roberts,Gail L. Woods,Gail L. Woods +7 more
TL;DR: The results suggest that the Fungitel assay may be most useful for excluding invasive fungal infection.
Journal ArticleDOI
Clinical and Laboratory Update on Blastomycosis
Michael Saccente,Gail L. Woods +1 more
TL;DR: Blastomycosis is endemic in regions of North America that border the Great Lakes and the St. Lawrence River, as well as in the Mississippi River and Ohio River basins, and is one of the great mimickers in medicine.
Journal ArticleDOI
High serum-free light chain levels and their rapid reduction in response to therapy define an aggressive multiple myeloma subtype with poor prognosis
Frits van Rhee,Vanessa Bolejack,Klaus Hollmig,Mauricio Pineda-Roman,Elias Anaissie,Joshua Epstein,John D. Shaughnessy,Maurizio Zangari,Guido Tricot,Abid Mohiuddin,Yazan Alsayed,Gail L. Woods,John Crowley,Bart Barlogie +13 more
TL;DR: Unlike baseline and follow-up analyses of serum and urine M-proteins, high SFLC levels at baseline-reflecting more aggressive disease- and steeper reductions after therapy identified patients with inferior survival.
Journal ArticleDOI
Comparison of Six Methods of Extracting Mycobacterium tuberculosis DNA from Processed Sputum for Testing by Quantitative Real-Time PCR
TL;DR: Of the extraction methods evaluated, IDI lysis tubes provided the greatest yield of mycobacterial DNA, and the procedure can be completed in less than 1 h versus 2.5−3 h for the QIAGEN extraction.